Drug intelligence / Profile preview

goniothalamin

Development stage
Preclinical
Modality
Small Molecules
Administration
Intraperitoneal, Oral
01

Overview

Goniothalamin is a naturally occurring styryl lactone secondary metabolite isolated from plants of the genus *Goniothalamus*. It exhibits potent cytotoxic, pro-apoptotic, and antiproliferative activities against various cancer cell lines, including breast, lung, and colorectal cancers. Its mechanism of action involves the depletion of intracellular glutathione (GSH) and the generation of reactive oxygen species (ROS), leading to oxidative stress, protein glutathionylation, and cell cycle arrest at the G2/M phase. Additionally, goniothalamin acts as a covalent inhibitor of Exportin-1 (XPO1/CRM1) by binding to its reactive cysteine residue (Cys528), thereby blocking nuclear export. It has also been shown to reactivate mutant p53 (specifically the R175H mutant) by facilitating functional restoration through thiolation of redox-sensitive cysteines in the DNA-binding domain.

Other names
(6R)-(+)-goniothalamin(6R)-5,6-dihydro-6-[(1E)-2-phenylethenyl]-2H-pyran-2-one(R)-(+)-goniothalamin(R)-goniothalamin5,6-dihydro-6-styryl-2-pyronone
02

Targets

XPO1 (Exportin-1)GSH (Glutathione)

Beyond the preview

Go deeper on goniothalamin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on goniothalamin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call